» Authors » Iacopo Gianassi

Iacopo Gianassi

Explore the profile of Iacopo Gianassi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 30
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cutruzzula R, Laudicina S, Bagala A, Caroti L, Bartiromo M, Gianassi I, et al.
Clin Nephrol Case Stud . 2023 Apr; 11:66-71. PMID: 37114160
Background: Among different forms of de novo focal segmental glomerulosclerosis (FSGS), which can develop after kidney transplantation (KTx), collapsing glomerulopathy (CG) is the least frequent variant, but it is associated...
2.
Allinovi M, Palazzini G, Lugli G, Gianassi I, Dallari L, Laudicina S, et al.
Diagnostics (Basel) . 2022 Dec; 12(12). PMID: 36552997
Intradialytic hypotension (IDH) is a frequent and well-known complication of hemodialysis, occurring in about one third of patients. An integrated approach with different methods is needed to minimize IDH episodes...
3.
Allinovi M, Trivioli G, Lugli G, Villanti M, Gianassi I, Antognoli G, et al.
Nephrol Dial Transplant . 2021 Nov; 37(4):789-791. PMID: 34788862
No abstract available.
4.
Allinovi M, Laudicina S, Dallari L, Gianassi I, Dervishi E, Biagini M, et al.
Hemodial Int . 2021 Jun; 25(4):E48-E52. PMID: 34164903
Introduction: Considering that patients on dialysis showed a poor outcome during COVID-19 pandemic, and that COVID-19 symptoms in dialysis patients are often mild or absent, each dialysis unit should implement...
5.
Gianassi I, Allinovi M, Caroti L, Cirami L
World J Nephrol . 2019 Nov; 8(7):109-117. PMID: 31750091
Background: Interferons (IFNs) are characterized by a wide range of biological effects, which justifies their potential therapeutic use in several pathologies, but also elicit a wide array of adverse effects...